NEW YORK (GenomeWeb News) – The Joslin Diabetes Center will use Metabolon’s biochemical profiling technology in human clinical and animal studies of insulin resistance and type 2 diabetes, Metabolon said today.
 
Research Triangle Park, NC-based Metabolon also will assess the translatability of its human insulin resistance biomarkers when conducting the Joslin diabetic animal model studies. In addition, the partners will collaborate on further validation studies of human biochemical markers of insulin resistance.
 

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Senator Elizabeth Warren (D-Mass.) has released the results of a genetic ancestry analysis, the Boston Globe reports.

Retraction Watch's Ivan Oransky and Adam Marcus report that Harvard Medical School and Brigham and Women's Hospital have recommended that more than 30 papers from a former researcher be retracted.

Thomas Steitz, who won the 2009 chemistry Nobel Prize for his ribosome work, has died, the Washington Post reports.

In PLOS this week: mechanisms for genes implicated in coronary artery disease, rumen microbes and host genetics influence cow methane production, and more.